Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07025044 · ClinicalTrials.gov registry record
Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections
A clinical trial of Urge Incontinence and Overactive Bladder (OAB), sponsored by Alexis Dieter.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT07025044: Recruiting study of Urge Incontinence and Overactive Bladder (OAB), sponsored by Alexis Dieter.
NCT07025044 is a study of Urge Incontinence and Overactive Bladder (OAB) that is actively recruiting participants, run by Alexis Dieter. The registered enrollment target is 40 participants, below the 96-participant average among 7 other Urge Incontinence trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07025044, a study of Urge Incontinence and Overactive Bladder (OAB), is actively recruiting participants, sponsored by Alexis Dieter.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Single-site prospective observational pilot feasibility study of women with overactive bladder/urge urinary incontinence undergoing onabotulinum toxin type A intradetrusor injections in order to achieve the following objectives: * Establish a record of successful collaboration with Dr. Ravel, an expert researcher in the female microbiome based at the University of Maryland * Demonstrate the investigators' ability to recruit subjects from the diverse population of postmenopausal women undergoing BTX for OAB within MedStar Health Urogynecology clinics * Collect, process and analyze urine specimens collected prior to and 4-weeks after BTX injection, and to compare the GU microbiome of self-collected versus clinic-collected samples * Assess response to BTX treatment and explore rates of and risk factors for urinary tract infection and incomplete voiding requiring catheterization within the first 4-weeks after BTX
Primary Outcome
recruitment of 40 eligible subjects from our diverse population of postmenopausal women undergoing BTX for OAB
Conditions Studied
Interventions
- DRUG onabotulinum toxin type a
Study Locations (1)
District of Columbia
- MedStar Urogynecology Clinic - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-09-03 |
| Est. Completion | 2026-06-01 |
What NCT07025044 shows while recruiting
NCT07025044 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 96-participant average among 7 other Urge Incontinence trials with a reported enrollment target (58% lower).
The record links to 2 conditions, with Urge Incontinence appearing as the primary indexed condition, and to 1 intervention - of which onabotulinum toxin type a is the first listed.
NCT07025044 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT07025044 about?
NCT07025044 is a clinical study titled "Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections". Single-site prospective observational pilot feasibility study of women with overactive bladder/urge urinary incontinence undergoing onabotulinum toxin type A intradetrusor injections in order to achieve the following objectives: * Establish a record of successful collaboration with Dr. Ravel, an ex...
What is the current status of trial NCT07025044?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-09-03. Estimated completion is 2026-06-01.
What conditions does trial NCT07025044 study?
This clinical trial studies the following conditions: Urge Incontinence, Overactive Bladder (OAB).
What interventions are being tested in trial NCT07025044?
The interventions under investigation include: onabotulinum toxin type a (DRUG).
Who is sponsoring clinical trial NCT07025044?
This trial is sponsored by Alexis Dieter, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07025044 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urge Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Percutaneous Nerve Evaluation Trial Time
RECRUITING · NA
-
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
RECRUITING · NA
-
rTMS in Overactive Bladder
RECRUITING · NA
-
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
RECRUITING · NA
-
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
COMPLETED · Phase 4
-
Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI